[Suppression of reaginic antibodies]. 1977

A H Sehon, and W Y Lee

The primary as well as an ongoing IgE response to the haptens--2,4-dinitrophenyl (DNP) and benzylpénicilloyl (BPO) determinants--were readily abrogated in an immunologically specific manner by the administration of conjugates consisting of the corresponding hapten coupled to the isologous, non-immunogenic murine gamma globulins (MgammaG), i. e., DNP8-MgammaG or BPO9-MgammaG. The epitope density of the DNPx-MgammaG and BPOx-MgammaG was shown to play a dominant role in determining whether or not these conjugates were tolerogenic. Using the adoptive transfer system in mice, it was demonstrated that this method of immunosuppression was not due to the formation of suppressor cells, but involved the elimination of hapten specific IgE-forming Bepsilon cells or the inactivation of these cells through the blockade of their antigen binding receptors. This method of suppression of anti-hapten IgE antibodies, by the use of conjugates of haptens with isologous gamma-globulins, proved also effective in rats and dogs.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D011935 Reagins Antibodies, especially IGE, that bind to tissue of the same species so that ANTIGENS induce HISTAMINE RELEASE and other vasoactive agents. HYPERSENSITIVITY is the clinical manifestation. Homocytotropic Antibodies,Reagin
D004136 Dinitrobenzenes Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions. Dinitrobenzene,Dinitrophenyl Compound,Dinitrophenyl Compounds,Dinitrotoluene,Dinitrotoluenes,Compound, Dinitrophenyl
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

A H Sehon, and W Y Lee
January 1970, Folia allergologica,
A H Sehon, and W Y Lee
January 2015, Current topics in microbiology and immunology,
A H Sehon, and W Y Lee
January 1970, Annual review of medicine,
A H Sehon, and W Y Lee
November 1978, The Journal of allergy and clinical immunology,
A H Sehon, and W Y Lee
January 1983, Clinical allergy,
A H Sehon, and W Y Lee
January 1957, The Journal of allergy,
A H Sehon, and W Y Lee
April 1967, Nature,
A H Sehon, and W Y Lee
November 1973, The Veterinary record,
A H Sehon, and W Y Lee
January 1969, International archives of allergy and applied immunology,
Copied contents to your clipboard!